glp-1 drug made by eli lilly Lilly's $1 Trillion Boom: Inside Dave Ricks' Weight-Loss Bet FDA approves tirzepatide, Eli Lilly's
Description
In the Satiety and Clinical AdiposityLiraglutide Evidence (SCALE) Diabetes trial, a total of 846 overweight and obese patients with T2D were randomly assigned to receive 3.0 or 1.8 mg of liraglutide or placebo for 56 weeks
Once there are eight tools instead of one, the hard part becomes matching the right agent to the right person and actually delivering it: coverage, titration, monitoring, adherence
doi: 10.1016/j.jcjd.2024.08.002
doi: 10.1097/ALN.0000000000004752 [DOI] [PubMed] [Google Scholar] 74.Milder DA, Milder TY, Liang SS, et al
